🇺🇸 FDA
Pipeline program

Albutein 50 g/l solución para perfusión.

IG1407

Phase 3 small_molecule active

Quick answer

Albutein 50 g/l solución para perfusión. for Subjects with cirrhosis with ACLF-1b, ACLF-2, or ACLF-3a detected either at admission or during hospitalization is a Phase 3 program (small_molecule) at Instituto Grifols S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Instituto Grifols S.A.
Indication
Subjects with cirrhosis with ACLF-1b, ACLF-2, or ACLF-3a detected either at admission or during hospitalization
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials